Risk factors
Oragenics (OGEN) risk factors
Item 1A of every Oragenics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors60 risks6 new5 dropped10 reworded
Oragenics faces severe going-concern doubts and needs capital to fund ONP-002 trials. Stock dilution risks are elevated due to Series F and H preferred conversions. The company relies on sole-source or limited third-party suppliers for ONP-002.
Filed Mar 16, 2026 - FY2024 10-K risk factors59 risks
Oragenics faces substantial going concern doubt with an accumulated deficit of $217 million and negative cash flows.
Filed Mar 14, 2025